Pacira BioSciences, Inc. (PCRX)

Healthcare · Drug Manufacturers Specialty Generic · NASDAQ

Pacira BioSciences, Inc. (PCRX) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $1.02B, a trailing price-to-earnings ratio of 9.8 and a free-cash-flow yield of 11.9%. Over the most recent reported fiscal year, revenue grew 3.6% and free cash flow per share fell 21.5%.

Market cap	$1.02B
Trailing P/E	9.8
FCF yield	11.9%
Revenue growth (YoY)	+3.6%
EPS growth (YoY)	-18.1%
FCF/share growth (YoY)	-21.5%
Exchange	NASDAQ
Sector	Healthcare
Industry	Drug Manufacturers Specialty Generic

Explore live PCRX data on Nama Insights →

Recent Congressional trades

Pacira BioSciences, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →

Member	Chamber	Trade	Amount	Disclosed
Tom Malinowski	House	Buy	$1,001 - $15,000	May 31, 2021
Tom Malinowski	House	Buy	$1,001 - $15,000	Feb 1, 2021
Tom Malinowski	House	Buy	$1,001 - $15,000	Feb 1, 2021
Tom Malinowski	House	Buy	$1,001 - $15,000	Dec 1, 2020
Tom Malinowski	House	Buy	$15,001 - $50,000	Oct 1, 2019
Tom Malinowski	House	Buy	$1,001 - $15,000	Sep 1, 2019
Tom Malinowski	House	Buy	$15,001	Jun 1, 2019
Tom Malinowski	House	Buy	$15,001 - $50,000	Jun 1, 2019
Tom Malinowski	House	Buy	$15,001 - $50,000	Jun 1, 2019